Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 74

    Govt Recovers Just 7.8% of Rs 4,928 cr Drug Overcharging Fine

    Govt Recovers Just 7.8% of Rs 4,928 cr Drug Overcharging Fine

    savita thakur thakur11 May 2016 12:26 PM IST
    New Delhi : The government has been able to recover just Rs 386.07 crore as fine, a mere 7.83 per cent of the total Rs 4,928.09 crore which has been...
    Inefficient Prescribing Costs Billions of Healthcare Dollars : JAMA Study

    Inefficient Prescribing Costs Billions of Healthcare Dollars : JAMA Study

    savita thakur thakur10 May 2016 3:57 PM IST
    In the U.S. between 2010 and 2012, nearly $73 billion was spent on brand name medications instead of less expensive alternatives, according to a new...
    Pfizer affected by NLEM list expansion

    Pfizer affected by NLEM list expansion

    savita thakur thakur9 May 2016 11:27 AM IST
    New Delhi : Terming the expansion of National List of Essential Medicines (NLEM) 'a dampener', drug firm Pfizer said the government's move has...
    Painkiller Training Should be must for Physicians: FDA Panel

    Painkiller Training Should be must for Physicians: FDA Panel

    savita thakur thakur8 May 2016 11:17 AM IST
    Washington : Doctors who prescribe painkillers should be required to undergo training aimed at reducing misuse and abuse of the medications, according...
    Govt ups initiatives to set up funds to promote pharma sector

    Govt ups initiatives to set up funds to promote pharma sector

    savita thakur thakur8 May 2016 11:16 AM IST
    New Delhi : The government is taking a number of initiatives to help pharma firms upgrade technology and promote drug discovery and innovation in the...
    Drug Pricing Regime Needs to be Predictable,Transparent:Sanofi

    Drug Pricing Regime Needs to be Predictable,Transparent:Sanofi

    savita thakur thakur6 May 2016 9:36 AM IST
    New Delhi : Government must not place the entire burden of access to healthcare on the pharmaceutical industry alone, Sanofi India has said while...
    NPPA Examining 92 Applications to Fix Price of New FDCs

    NPPA Examining 92 Applications to Fix Price of New FDCs

    savita thakur thakur3 May 2016 10:59 AM IST
    New Delhi : National drug price regulator NPPA is currently evaluating 92 applications for retail price fixation of new fixed dose combinations,...
    AYUSH drug makers to offer alternatives to banned FDC drugs

    AYUSH drug makers to offer alternatives to banned FDC drugs

    Geeta Sharma Sharma3 May 2016 10:59 AM IST
    Tamil Nadu:In response to the union government's recent ban on the fixed dose drug combinations (FDC), the Tamil Nadu Ayurveda, Siddha and Unani...
    Include genetic diseases in Medical Insurance: Delhi Court

    Include genetic diseases in Medical Insurance: Delhi Court

    savita thakur thakur2 May 2016 1:08 PM IST
    New Delhi: "Good health is a justiciable fundamental right", a Delhi court has said while observing that Prime Minister Narendra Modi's ambitious...
    Parl Panel Moots One-Time Settlement of Drug Overpricing Cases

    Parl Panel Moots One-Time Settlement of Drug Overpricing Cases

    savita thakur thakur1 May 2016 10:40 AM IST
    A Parliamentary panel has suggested a one-time settlement of drug overpricing cases that regulator NPPA is currently fighting with the pharmaceutical...
    Government May Move Supreme Court to Club all FDC Drugs Ban Cases

    Government May Move Supreme Court to Club all FDC Drugs Ban Cases

    savita thakur thakur1 May 2016 10:22 AM IST
    New Delhi : Government today said it may move the Supreme Court asking it to club all cases related to its ban on 344 fixed dose combination drugs...
    HC Allows Biocon Mylan to Continue Manufacturing Cancer Drugs

    HC Allows Biocon Mylan to Continue Manufacturing Cancer Drugs

    savita thakur thakur29 April 2016 1:58 PM IST
    New Delhi : The Delhi High Court has allowed pharma firms, Biocon Ltd and Mylan Pharmaceuticals Pvt Ltd, to continue with manufacture and marketing...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok